Medically Reviewed by: Dr. Mauada, MD, MBBS — DHA-Licensed Physician. 3,000+ vaccination sessions administered across Dubai. Reviewed in accordance with WHO Meningococcal Vaccination Guidelines. Last updated: April 2026
The MENACTRA vaccine Dubai is a meningococcal conjugate vaccine (MenACWY) designed to protect against four major strains of Neisseria meningitidis:
Serogroups A, C, W, and Y
These bacteria can cause meningitis (brain infection) and meningococcal septicemia (blood infection) — both of which can progress rapidly and become life-threatening within hours.
Administered by DHA-licensed physicians at your home, hotel, or clinic across Dubai, MENACTRA is a non-live conjugate vaccine manufactured by Sanofi Pasteur. Each 0.5 mL intramuscular injection provides strong, long-lasting protection against invasive meningococcal disease.
Dr. Mauada, DHA-Licensed Physician:
"MENACTRA is one of the most critical vaccines for adolescents and travelers. Meningococcal disease can progress extremely quickly — vaccination is the most effective protection."
MENACTRA vaccine Dubai price: 1275 AED per 0.5 mL dose — including DHA-licensed clinician, cold-chain maintained vaccine, sterile equipment, pre-vaccination screening, and same-visit certificate.
| Service | Price (AED) |
|---|---|
| MENACTRA Single Dose | 1275 AED |
| Booster Dose | 1275 AED |
| Mobile Service (Home / Hotel / Office) | 1275 AED — No surcharge |
| Family / Group Visit | Ask for package pricing |
| Same-Day Booking | Available across Dubai |
★★★★★ 4.9/5 — 140+ verified patient reviews
MENACTRA is recommended for children, adolescents, and adults, especially those at increased risk of meningococcal disease.
The following groups most commonly receive MENACTRA in Dubai:
Adolescents (routine vaccination)
Travelers to high-risk regions (Africa, Saudi Arabia, etc.)
Pilgrims performing Hajj or Umrah (mandatory requirement)
Students living in dormitories or shared accommodation
Individuals with weakened immune systems
Healthcare workers and laboratory staff
Children and adults requiring meningitis protection
Individuals with splenic disorders or complement deficiencies
Each 0.5 mL dose contains purified polysaccharides conjugated to diphtheria toxoid.
| Component | Role |
|---|---|
| Meningococcal polysaccharides (A, C, W, Y) | Active antigens |
| Diphtheria toxoid protein | Carrier protein for enhanced immune response |
| Sodium phosphate buffer | Stability |
| Water for injection | Solvent |
MENACTRA is a non-live vaccine and cannot cause meningococcal infection.
MENACTRA works by stimulating the immune system to produce bactericidal antibodies against meningococcal bacteria.
These antibodies:
Recognise and destroy bacteria before infection occurs
Prevent bacterial invasion into the bloodstream and brain
Provide protection against meningitis and septicemia
The conjugate design ensures a stronger and longer-lasting immune response, especially in children and adolescents.
| Age Group | Recommended Schedule |
|---|---|
| Children (9–23 months) | 2 doses (3 months apart) |
| Children (2–10 years) | Single dose |
| Adolescents (11–18 years) | Single dose + booster if required |
| Adults | Single dose |
| High-risk individuals | Booster every 5 years |
Your DHA-licensed physician confirms the optimal schedule based on age and risk profile.
| Timeline | Immune Response |
|---|---|
| Day 0 | Vaccination administered |
| 7–10 Days | Antibody response begins |
| 2 Weeks | Protective immunity develops |
| Long-term | Sustained protection with booster if required |
Before:
Medical screening including vaccination history, travel plans, and risk assessment.
During (10–15 minutes):
Injection administered intramuscularly into the upper arm (deltoid muscle).
After:
15-minute observation
Mild soreness or redness possible
Resume normal activities
Certificate issued same visit
| Contraindication | Detail |
|---|---|
| Severe allergic reaction | To vaccine components |
| Acute febrile illness | Delay vaccination |
| Previous severe reaction | Requires physician evaluation |
We provide MENACTRA vaccination at home across all Dubai areas with no travel surcharge.
Areas covered:
Dubai Marina, JBR, Downtown Dubai, Business Bay, DIFC, Palm Jumeirah, JLT, Emirates Hills, Jumeirah, Al Barsha, Dubai Hills, Mirdif, Arabian Ranches, Bluewaters Island, Deira, Bur Dubai, and surrounding areas.
Same-day bookings available.
What does MENACTRA protect against?
Meningococcal bacteria causing meningitis and bloodstream infections (A, C, W, Y strains).
Is MENACTRA required for Hajj or Umrah?
Yes — it is mandatory for pilgrims traveling to Saudi Arabia.
How long does protection last?
Typically 3–5 years, with boosters recommended for high-risk individuals.
Is MENACTRA safe?
Yes — widely used globally with strong safety data.
What are common side effects?
Mild soreness, redness, or low-grade fever.
Can it be combined with other vaccines?
Yes — can be administered alongside travel vaccines.
Dr. Mauada leads Medilife’s vaccination services across Dubai with over 3,000+ clinical sessions performed.
MENACTRA is one of the most important vaccines for travel and adolescent protection, particularly for Hajj, Umrah, and high-risk environments.
Each consultation includes:
Full vaccination history review
Travel and risk assessment
Safe administration
Certification and follow-up planning
Frequently Bought Together
Products from this Seller
View All
Subscribe our newsletter for coupon, offer and exciting promotional discount..
Share with Friends
Trading is more effective when you share products with friends!Share you link
Share to